ANNE NGUYEN: Open Payments
NPI 1801351978 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 19 payments from 9 companies in 2025. Trend: 2023 $43 · 2024 $0 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $94 |
| Janssen Pharmaceuticals, Inc | 3 | $80 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Shionogi Inc | 1 | $44 |
| Bausch Health US, LLC | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Lundbeck LLC | 1 | $27 |
Products named: Auvelity, SPRAVATO, REXULTI, COBENFY, Fetroja, APLENZIN, CAPLYTA, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
